S&P 500 7,666.45 +0.19%
Nasdaq 26,871.60 +0.04%
S&P/TSX 35,154.76 −0.23%
Apple 330.32 −0.81%
Nvidia 230.86 +1.09%
Microsoft 512.80 −0.02%
Shopify 212.10 +0.56%
Royal Bank 277.86 −0.74%
CAD/USD 0.7026 +0.02%
PRE-MKT · 05:00 ET
Market ClerkRecap
Fri Oct 2 · pre-market3 signals on Oct 1308 insider buys this week · $10330.5BCIRO short report next: Oct 15The week ahead

TSHA

Taysha Gene Therapies, Inc.
NASDAQ · HEALTH CARE · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
4.74
−0.13 −2.67%
USD · close Oct 1

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

MKT CAP $1.5BP/E —DIV YIELD —FCF YIELD -8.58%REV TTM $5.5M −32.3%NET INCOME −$149.6MNET CASH $417.1M52W 3.83 – 6.98SEC XBRL · TTM TO Invalid Date

What TSHA had to tell the SEC

FORM 8-K · TWO YEARS · MOST RECENT FIRST
No 8-K filings from TSHA on record yet. The events worker reads new filings each morning; older ones appear as the sweep reaches them.

Items read from each filing’s EDGAR index page; labels are ours. Every tracked company’s 8-Ks, most serious first.

Watch TSHA. Know when insiders buy.
One email the day a filing lands. Free.